Previous Close | 0.3635 |
Open | 0.3650 |
Bid | 0.3301 x N/A |
Ask | 0.3754 x N/A |
Day's Range | 0.3436 - 0.3726 |
52 Week Range | 0.2647 - 1.6520 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Nov 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BAINBRIDGE, Ga., October 28, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In r
BAINBRIDGE, Ga., October 15, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading, next-generation biotechnology company focused on the production of biodegradable materials, today announced that Richard Altice, a current Danimer director and former President and Chief Executive Officer of NatureWorks, has been named Interim Chief Executive Officer, effective immediately. Mr. Altice succeeds Stephen Croskrey, who previously announced his intention to retire after m